- Presentations
- 6
- Markets
- 1
Livmarli is a brand of Maralixibat marketed by Mirum Pharmaceuticals, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Maralixibat
- Brand owner
- Mirum Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 19 mg/mL oral solution, 9.5 mg/mL oral solution, 10 mg tablet, 15 mg tablet, 20 mg tablet, 30 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Livmarli 19 mg/mL oral solutionOral | Mirum Pharmaceuticals | US FDA | Available on request |
| Livmarli 9.5 mg/mL oral solutionOral | Mirum Pharmaceuticals | US FDA | Available on request |
| Livmarli 10 mg tabletOral | Mirum Pharmaceuticals | US FDA | Available on request |
| Livmarli 15 mg tabletOral | Mirum Pharmaceuticals | US FDA | Available on request |
| Livmarli 20 mg tabletOral | Mirum Pharmaceuticals | US FDA | Available on request |
| Livmarli 30 mg tabletOral | Mirum Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Livmarli
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.